Augusta Oncology Associates

Augusta, Georgia 30901-5104

0 studies enrolling now · 14 studies all time

What they study most

Breast Cancer, Breast Neoplasm, Cachexia, Carcinoma, Non-Small-Cell Lung, Clear Cell Renal Carcinoma, Kidney Cancer, Locally Recurrent, Lung Cancer, Metastatic Breast Cancer, Metastatic Breast Cancer ( HER2 Negative), Multiple Myeloma, Non-Small Cell Lung Cancer

Studies at this site

• A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer — Completed
• TroVax Renal Immunotherapy Survival Trial — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer — Completed
• Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer — Completed
• Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) — Completed
• Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. — Completed
• Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer — Status unconfirmed
• Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer — Completed
• S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer — Completed
• Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients — Completed
• Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC — Completed
• A Multiple Myeloma Trial in Patients With Bone Metastases — Completed
• Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer — Completed